Prognostic value of Muc5AC in gastric cancer: A meta-analysis

Table 2 Subgroup analysis of pooled hazard ratio in gastric cancer patients with decreased Muc5AC expression

	No. of studies	No. of patients	Pooled HR (95%CI)	Heterogeneity
				I2	P-value
Study location
East Asia	4	1152	1.39 (1.03-1.88)	33%	0.21
Non-East Asia	2	244	1.31 (0.92-1.86)	62%	0.10
Sample size
≥ 200	4	1276	1.34 (1.05-1.71)	0%	0.63
< 200	2	120	1.49 (0.76-2.94)	81%	0.02
Cut-off value
≥ 10%	4	1106	1.32 (1.03-1.7)	14%	0.32
< 10%	2	290	1.54 (0.87-2.71)	71%	0.06